Skip to main content
RYTM filings

Corporate insider profile

David P Meeker Filing Activity

Latest reported as President and CEO of RHYTHM PHARMACEUTICALS, INC. (RYTM).

Purchase filings
0
Reported companies
1
Net open-market value
-$5,133,440.00
Latest transaction
Sep 14, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 14, 2026RHYTHM PHARMACEUTICALS, INC. (RYTM)President and CEOSale50,000$102.67$5,133,440